BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels
Collaboration assembles core capabilities across biofuels value chain to develop biodiesel production using sugar feedstocks
BP and Martek Biosciences Corporation announced the signing of a Joint Development Agreement (JDA) to work on the production of microbial oils for biofuels applications. The partnership combines a broad technology platform and operational capabilities to advance the development of a step-change technology for the conversion of sugars into biodiesel.
Under the terms of the multi-year agreement, Martek and BP will work together to establish proof of concept for large-scale, cost effective microbial biodiesel production through fermentation.
“Martek is pleased to partner with BP’s Alternative Energy team, to combine our unique algae-based technologies and intellectual property for the creation of sustainable and affordable technology for microbial biofuel production,” said Steve Dubin, Martek CEO. “BP’s global leadership and commitment to alternative energy solutions complements Martek’s own commitment to responsible and sustainable products and production.”
“As an alternative to conventional vegetable oils, we believe sugar to diesel technology has the potential to deliver economic, sustainable and scaleable biodiesel supplies. In partnering with Martek, we combine the world’s leading know-how in microbial lipid production with our expertise in fuels markets and applications, and our more recent experience in biofuels production and commercialization,” says Philip New, CEO BP Biofuels.
The technology has been demonstrated in Martek’s field for more than 20 years and the challenge is to adapt this technology to the needs of the biofuels market, in terms of product profile and economics. Philip New added, “This technology is also a perfect fit with our other strategic choices for biofuels, all based on sustainable feedstocks and fermentation to produce advanced biofuels. It is part of our approach of integrating sugar cane and lignocellulosic biofuels with advanced technologies to produce products with a wide range of uses.”
BP has agreed to contribute up to $10 million to this initial phase of the collaboration which leverages Martek’s significant expertise in microbial oil production and BP’s production and commercialization experience in biofuels as the platform for the joint development effort. Martek will perform the biotechnology research and development associated with this initial phase, whilst BP will contribute to its integration within the biofuels value chain. All intellectual property owned prior to the execution of the JDA will be retained by each respective company, and all intellectual property developed during the JDA will be owned by BP, with an exclusive licence to Martek for application and commercialization in nutrition, cosmetic and pharmaceutical applications. Additionally, each party is entitled to certain commercial payments from technology commercialized in the other party’s field.
Other news from the department business & finance
These products might interest you

Fully automated hydrogenation reactor BR/H2 by Berghof
Fully automated hydrogenation reactor: Precise and safe hydrogenation at the flick of a switch
Optimised process control with leakage tests, gas consumption measurement and modular expandability

BRC - Berghof Reactor Controller by Berghof
BRC - complete package for data acquisition, storage and control of all process parameters
Touch controllers are easy to use and provide quick access to all important functions

Berghof Reaktortechnologie - Hoch- und Niederdruckreaktoren, Druckbehälter und metallfreie Reaktoren by Berghof
Safe high- and low-pressure systems for aggressive media
Corrosion-resistant reactors with PTFE lining - individually configurable

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.